Recent Updates
Recently added Catalysts
HBIO Positive Sentiment Score: 65/100

Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

Tuesday, October 29, 2024 2 min read
Key Takeaway: Harvard Bioscience, Inc. has announced that it will hold its earnings conference call for the third quarter of 2024 on November 7, 2024, at 8:00 AM ET. The financial results for the quarter ending September 30, 2024, will be released prior to the market opening on the same day. Interested participants can register to join the call or access the audio-only webcast through the company's investor website. This event reflects Harvard Bioscience's commitment to transparency and investor engagement.

Market Sentiment Analysis

POSITIVE FACTORS

  • Scheduled earnings conference call indicates proactive communication.
  • Harvard Bioscience continues to engage with investors efficiently.
  • The company's financial results could showcase positive growth.

Full Press Release Details

HOLLISTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2024 before the market opens on November 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.
Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Chief Financial Officer

Frequently Asked Questions

When will Harvard Bioscience announce its financial results?

Harvard Bioscience will announce its financial results on November 7, 2024.

What time is the conference call for the financial results?

The conference call is scheduled for 8:00 a.m. Eastern Time.

How can participants register for the conference call?

Participants must register to receive dial-in numbers and a unique PIN.

Where can I find financial information from the call?

Financial information will be available on Harvard Bioscience's Investor Relations page.

What services does Harvard Bioscience provide?

Harvard Bioscience develops technologies for life science research and therapy development.

Tags: HBIO Viatris Investor Conferences Healthcare earnings call financial results Harvard Bioscience life sciences
Last updated: Oct 29, 2024